IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
10 Mai 2023 - 2:30PM
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), was recently
named on Forbes’ latest list of America’s Best Small Companies for
2023. Iradimed is a leader in the development of innovative
magnetic resonance imaging (“MRI”) medical devices and the only
known provider of a non-magnetic intravenous (“IV”) infusion pump
system, and non-magnetic patient vital signs monitoring systems
that are designed for use during MRI procedures.
To find the 100 best performers, Forbes used data from FactSet
to compile its annual list of America’s Best Small Companies.
Forbes screened more than 1,000 companies with a market value
between $300 million and $2 billion to find 541 companies that had
both positive sales growth over the past 12 months and a share
price of at least $5. Financial institutions, REITs, utilities,
royalty trusts, and limited partnerships were excluded, as were
companies that have been public for less than one year. The ranking
is based on earnings growth, sales growth, return on equity, and
total stock return for the latest 12 months available and over the
last five years.
"I am incredibly honored and proud that Iradimed has been named
one of America’s Top 100 Small Companies by Forbes,” said Roger
Susi, President and Chief Executive Officer of the Company. “This
recognition is a testament to the hard work and dedication of our
entire team, and we are grateful for the support of our customers
and shareholders. We remain committed to delivering unique patient
safety devices to our customers, exceptional value to our
shareholders, and driving sustained growth for our business."
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of
innovative Magnetic Resonance Imaging (“MRI”) compatible medical
devices. We develop, manufacture, market, and distribute
MRI-compatible medical devices and accessories, disposables, and
services relating to them.
We are the only known provider of a non-magnetic intravenous
(“IV”) infusion pump system that is specifically designed to be
safe for use during MRI procedures. We were the first to develop an
infusion delivery system that largely eliminates many of the
dangers and problems present during MRI procedures. Standard
infusion pumps contain magnetic and electronic components which can
create radio frequency interference and are dangerous to operate in
the presence of the powerful magnet that drives an MRI system. Our
patented MRidium® MRI compatible IV infusion pump system has been
designed with a non-magnetic ultrasonic motor, uniquely designed
non-ferrous parts, and other special features to safely and
predictably deliver anesthesia and other IV fluids during various
MRI procedures. Our pump solution provides a seamless approach that
enables accurate, safe, and dependable fluid delivery before,
during, and after an MRI scan, which is important to critically ill
patients who cannot be removed from their vital medications, and
children and infants who must generally be sedated to remain
immobile during an MRI scan.
Our 3880 MRI-compatible patient vital signs monitoring system
has been designed with non-magnetic components and other special
features to safely and accurately monitor a patient’s vital signs
during various MRI procedures. The Iradimed 3880 system operates
dependably in magnetic fields up to 30,000 gauss, which means it
can operate virtually anywhere in the MRI scanner room. The
Iradimed 3880 has a compact, lightweight design allowing it to
travel with the patient from their critical care unit to the MRI
and back, resulting in increased patient safety through
uninterrupted vital signs monitoring and decreasing the amount of
time critically ill patients are away from critical care units. The
features of the Iradimed 3880 include wireless ECG with dynamic
gradient filtering; wireless SpO2 using Masimo® algorithms;
non-magnetic respiratory CO2; invasive and non-invasive blood
pressure; patient temperature, and; optional advanced multi-gas
anesthetic agent unit featuring continuous Minimum Alveolar
Concentration measurements. The Iradimed 3880 MRI-compatible
patient vital signs monitoring system has an easy-to-use design and
allows for the effective communication of patient vital signs
information to clinicians.
For more information please visit www.iradimed.com.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a5d9c4ea-3de4-487d-862b-89848f2df80a
Media Contact:
IRADIMED CORPORATION
(407) 677-8022
InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
iRadimed (NASDAQ:IRMD)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024